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3Overview
This thesis examines the diagnostic accuracy of the non-English versions
of Addenbrooke’s Cognitive Examination - Revised and III. It also investigates the
effect of age on the underlying abilities of mindfulness practice. This thesis is part
of a wider ongoing PhD project and joint with another D.Clin.Psy. thesis.
Part 1 is a systematic review investigating the evidence for the diagnostic
accuracy of the non-English updated versions of Addenbrooke’s Cognitive
Examination (ACE) - the ACE-Revised (ACE-R) and the ACE-III - in the diagnosis
of dementia. In total, 15 studies were included in the current review. The results
indicate that despite the evidence of diagnostic accuracy, the quality assessment
suggests that various sources of bias have compromised the validity of the evidence.
Part 2 is an empirical paper that reveals the findings of a study
investigating the effect of age on the underlying abilities of mindfulness practice.
A total of 55 older adults and 55 younger adults completed the mindfulness
measures alongside measures of executive functioning and mood. The results
suggest that older adults perform better in mindfulness measures of cognitive
control/awareness whereas younger adults perform better in mindfulness measures
of emotion regulation/acceptance. Clinical implications and limitations are
discussed with reference to future research.
Part 3 is a critical appraisal that provides a reflection on the process of
conducting the current project. It discusses wider clinical implications of
conducting research with older people and some of the challenges and issues
encountered during the process.
4Acknowledgment
I would like to dedicate this research project to everyone who made this
possible. I am grateful to all participants who took the time to participate in this
study. I would like to express my gratitude to my supervisors Dr. Joshua Stott and
Dr. Georgina Charlsworth who have gone the extra mile with guidance and
encouragement through this journey. I am sincerely thankful to my parents and
siblings for supporting me with great compassion. I am thankful to our hard
working research assistant Maya Patel for her help with data collection, and to my
co-researcher Catherine Bousfield for her help with checking the data. Finally,
thank you to all my fellow trainees and dear friends for their kindness.
5Table of Contents
Part 1: Literature Review………………………………………………..…..….8
The Diagnostic Accuracy of the Non-English Versions of Addenbrooke’s
Cognitive Examination—Revised and III
Abstract……………………………………………………………………..…….9
Introduction………..…….………………………………………………..…….10
- Dementia………………………………………..………….……………..…10
- Screening tools for Dementia………………..………….…………….……..10
- Addenbrooke’s Cognitive Examination (ACE)…………….…………..……11
- Diagnostic Accuracy …………………………………………….………….12
- Diagnostic Accuracy of ACE-R and ACE-III……………………………….15
- Current literature Review…………………………………………..……….16
Methods……………………………………………………………………...…..17
- Search Strategy………….….…………………………………….…………17
- Inclusion Criteria…………………………………………….….……..……17
-Exclusion Criteria…………………………………………….…….…….….17
- Data Extraction…………………………………..………..…………….…..18
- Quality Assessment…………………………….……………………………18
Results…………………………………………………………………..……….19
- Study selection…………………………………………………….……..19
- Summary of Results……………………………………………….……..19
- Discription of study characteristics………………………………………28
- Methodological review of the studies…………………..…………….….28
- Results of individual studies categorised by the language of translation..30
Discussion…………………………………………………………….…….……39
- Summary of Results……………..…………………………………..………39
- General Methodological and Conceptual Issues……………….……..……..40
- Issues to consider for translation and cultural adaptation……………………42
- Clinical and research implications…………………………..………………42
- Limitation of the Current Review………………………….….…………….43
- Areas for Future Research……………………………….…………….……44
- Conclusion…………………………………………………………….……44
References……………………………………………………………………….45
Part 2: Empirical Paper…………………………………………………….….53
6The Effect of Age on the Underlying Abilities of Mindfulness Practice
Abstract……………………………………………………………………..…..54
Introduction……………………………….………………………………..…..55
- Cognitive Control and Mindfulness……………………………………..…56
- Ageing and Cognitive Control………………………………………..……56
- Emotional Regulation and Mindfulness…………….………………..….…57
- Ageing and Emotional Regulation……………………………………..…..58
- Current Study……………………………………………………………….59
- Research Questions and Hypotheses……………………………………….59
Methods……………………………………….…………………………..…….60
- Design………………………………………………………………………60
- Participants……………………………………………………..………..…60
- Eligibility Criteria…………………………………………….……….60
- Inclusion and Exclusion Criteria………………………………………60
- Setting………………………..……………………………………………..61
- Ethics………….……………….……………………………….…………..61
- Sample Size……..………………………………..….…………..…..……..62
- Measures………..………………………………..…..…………..…………62
- Procedure………….……………………………….…………..….………..65
- Data Analysis………………………………………………………….……66
Results…………………………………………………………………….……..67
- Participants Characteristics…………………………………………………69
- Research Question 1………………………………..…………….…………72
- Research Question 2…………………………………………….…………..73
- Research Question 3……………………………………………….………..73
- Feasibility…………………………………………………………………...75
Discussion……………………………………………………………………….76
- Summary of the Results……………………………………………..……..76
- Interpretation of Findings……………………………….……………….…77
- Limitations……………………….…………………………………………79
- Clinical Implication…………………………………………..……….……80
- Future Research……………………………………………………….……81
References……………………………………………………………….…..…..82
Part 3: Critical Appraisal……………………………………………….….…..90
7- Introduction……………………….……………………………………..….91
- Wider Clinical Implications of Older Adult Research……………….……..91
- Reflections on Recruitment, Interviews, and Engagement…………...….….92
- Dealing with Dilemmas………………………………………..…………….94
- Issues in Evaluating Translated screening Measures………..……..…..……96
- Conclusion………………………………………………………….….……98
- References…………………………………………………..……..……...…99
Appendices………………………………………………………..………..….102
Appendix A: Ethical Approval Letter…………………………………….…….103
Appendix B: Information Sheet………………………………………….……..104
Appendix C: Consent Form………………………………………………….…106
Appendix D: Measures (PHILMS)……………………………………………..107
Appendix E: Joint Project Submission Declaration………………………….…109
List of Tables and Figures
Literature Review
Figure 1: Sensitivity and Specificity…………………………………….….……13
Figure 2: Receiving operative characteristic (ROC) curve……………..…….….14
Figure 3: Flowchart of search process………………………………..……….…20
Table 1: Study Characteristics……………………………………….…….…….21
Table 2: Diagnostic Accuracy and Quality assessment…………..……….……..25
Empirical Paper
Figure 1: Flow diagram for older adults (OA)…………………..….……………68
Figure 2: Flow diagram for younger adults (YA)………..…………..………..…68
Table 1: Participant Characteristics………………………………….…….…….69
Table 2: Differences among the Main Variables, Comparing Older Adults and
Younger Adults…………………………………………………….……………74
8Part 1: Systematic Review
The Diagnostic Accuracy of the Non-English Versions of
Addenbrooke’s Cognitive Examination—Revised and III
9Abstract
Objectives: To review the evidence for the diagnostic accuracy of the non-English
updated versions of Addenbrooke’s Cognitive Examination (ACE)—the ACE-
Revised (ACE-R) and the ACE-III—in the diagnosis of dementia.
Design: A systematic search was conducted on PsychINFO, MEDLINE, and
EMBASE. Studies that met the inclusion criteria were evaluated using a systematic
appraisal tool.
Results: The systematic search resulted in 15 studies that were eligible for the
current review (14 on the ACE-R and one on the ACE-III). Excellent diagnostic
accuracy presented across the non-English versions of the ACE-R and the ACE-III.
However, the ability of the studies was likely compromised in drawing conclusions
about sensitivity and specificity.
Conclusion: Despite the measures’ ability to distinguish between people with and
without dementia, the quality assessment of the studies revealed various sources of
bias that influenced the validity of the evidence.
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Introduction
Dementia
Dementia is an umbrella term for neurological, chronic, and progressive
brain disorders that primarily affect older people around the age of 65 and older
(World Health Organisation, 2012). It is a syndrome that leads to deterioration in
cognitive functioning, which differs from normal age-related decline in cognition.
Alzheimer’s Society estimated prevalence of dementia in the United Kingdom in
2015 was 850,000 people (Prince et al., 2014). Different types of dementia exist
and have distinct neuropsychological profiles (Salmon & Bondi, 1999).
Alzheimer’s disease is the most common cause of dementia. The estimated number
of older people diagnosed with Alzheimer’s disease is 520,000 in the United
Kingdom (Prince et al., 2014). Other common subtypes of dementia are vascular
dementia, dementia with Lewy bodies, and frontotemporal dementia. Some older
people have only one type of dementia, but some may present with more than one
type of dementia. An accurate clinical diagnosis of dementia at an early stage and
an early intervention that slows the progression of the disease can lead to a better
prognosis (National Institute for Health and Clinical Excellence, 2006).
Screening Tools for Dementia
Neuropsychological assessment is a major component of the clinical
process of diagnosing dementia and of developing an appropriate intervention plan.
It is a reliable diagnostic method that does not rely just on self-report of cognitive
functioning, which can lack validity, especially if the individual has cognitive
problems, but also relies on a battery of valid and reliable tests that give quantitative
and qualitative information on the different neuropsychological profiles that can
indicate cognitive impairment (Salmon & Bondi, 2009).
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Screening tools for dementia are used as diagnostic instruments in the
context of clinical interviews to identify patients who might have the condition.
Ideally, the tools are developed to be used for people who are at increased risk of
developing this specific condition and are used as an initial step to determine the
need for a full neuropsychological assessment, or as diagnostic tools in themselves
when a full neuropsychological assessment is not feasible because of client-related
factors (Cherbuin, Anstey, & Lipnicki, 2008). However, they are often used in
clinical practice as a diagnostic tool combined with a clinical interview.
Addenbrooke’s Cognitive Examination
Addenbrooke’s Cognitive Examination (ACE) is a brief (15-minute)
screening tool that is widely used in research and clinical settings to detect signs of
dementia. It is a 100-point test, and the United Kingdom version has a high cutoff
point of 88 for dementia with 93% sensitivity and 71% specificity and a low cutoff
point of 83 with 82% sensitivity and 96% specificity (Mathuranath et al., 2000).
This screening tool aims to evaluate five cognitive domains to enable detection and
monitoring of deterioration in cognitive functioning (Mathuranath et al., 2000) and
to aid detection of different subtypes of dementia that may present with different
profiles of impairment. ACE and ACE-R but not ACE-III incorporate the Mini
Mental State Examination (MMSE) (Folstein, Folstein, & McHugh, 1975) and
provides sub-scale scores for the cognitive domains of language, functioning
memory, and verbal fluency. While the five sub-scale scores have remained, the
ACE has developed over time to address weaknesses identified through research
and clinical practice. In 2006, a revised version of the ACE (ACE-R) was published
to make the measure easier to administer, and in 2013 the ACE-III was published.
In both cases, the content was modified to increase sensitivity and to facilitate cross-
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cultural adaptation (Hsieh et al., 2013; Mioshi et al., 2006), cutoff points remain the
same for newer versions.
Diagnostic Accuracy
Diagnostic tests are objective measures used clinically to detect or predict a
particular condition. In studies of the clinical or diagnostic accuracy of a
psychometric test, authors have aimed to evaluate the association between the
results of the test under evaluation and the condition status of a certain population
sample (Guyatt, Tugwell, Feeny, Haynes, & Drummond, 1986). Sensitivity and
specificity are statistical measures of an instrument’s performance in detecting the
target condition in those with the condition and its absence in those without. A good
diagnostic tool has both high sensitivity and high specificity.
Sensitivity refers to the ability of the test to accurately identify those with the
target condition. A test with a high sensitivity (100%) can be used to correctly detect
all people with the target condition. Negative results indicate the absence of the
target condition, and positive results indicate the presence of the condition (Altman
& Bland, 1994). Statistically, sensitivity can be reported as the following:
Sensitivity=
Specificity refers to the tool’s ability to detect people who are without the
target condition. A test with a high level of specificity (100%) can be used to
accurately show that healthy people do not have the condition (Altman & Bland,
1994). Mathematically specificity can be reported as the following:
Specificity =
Number of True Positives
Number of True Positives + Number of False Positives
Number of True Negatives
Number of True Negatives + Number of False Negatives
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For any diagnostic tool on an interval or ordinal scale, there will be a number
of possible thresholds or cutoff scores at which a decision is made that a person has
a condition or not. Rarely will any of these cutoff scores completely separate people
with or without the target condition. Some individuals with the target condition will
score positive (TP= True Positive), but some individuals with the target condition
will score negative (FN= False Negative). By contrast, some individuals without
the target condition will correctly be classified as negative (TN= True Negative),
but some individuals without the target condition will score positive (FP= False
Positive) (Altman & Bland, 1994). The distributions of the scores will overlap, as
shown in the graph below (Figure 1).
Figure 1. Sensitivity and Specificity.
In order to determine the best cutoff for identifying a particular condition, the
relationship between sensitivity and specificity at different cutoff points is
represented through use of receiver operating characteristic (ROC) curve analysis
(Metz, 1978). The ROC curve represents the association between sensitivity and
specificity for tests at different cutoff points. It plots the true positive values
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(sensitivity) against the false positive value (1-specificity) at different cutoff scores.
Every plotted point on the ROC curve represents the relationship between
sensitivity and 1-specificity at a particular cutoff point. The decision regarding
where to set the cutoff on a tool for identifying a condition is made on the basis of
the value of a cutoff that maximises sensitivity and specificity. The area under the
curve (AUC) of the ROC illustrates generally how well the instrument is able to
distinguish between people with or without the target condition (Zweig &
Campbell, 1993). A perfect test with sensitivity = 100% and specificity = 100% has
a ROC curve that looks like the normal line on Figure 2 below and has an AUC of
1 where the entire area of the chart is contained within the curve. If the AUC is
equal to 0.5, then the test is useless, and this is illustrated by the dotted line below
(Zweig & Campbell, 1993).
Figure 2. Receiving operative characteristic (ROC) curve.
The likelihood ratio (LR) for a positive or negative test provides an indication
of the diagnostic accuracy of the tool (Simel, Samsa, & Matcher, 1991). The LR of
a positive test is calculated using the probability that a person with the target
condition will have a positive result, divided by the probability of a person without
the condition having a positive result on the measure. The quality of the tool
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increases the more the LR increases from 1. The diagnostic odds ratio (OR) is
another measurement of diagnostic accuracy. It refers to the ability of the tool to
discriminate between people with or without the target condition. The higher the
OR score is, the better the screening tool performance (Glas, Lijmer, Prins, Bonsel,
& Bossuyt, 2003). Youden’s index (Youden’s J statistic) is another statistical test
used occasionally in conjunction with ROC analysis to evaluate diagnostic
accuracy. The maximum value of the index indicates the optimal cutoff point of a
diagnostic test. It is illustrated graphically as the highest point that is equivalent to
the area under the ROC (J = Sensitivity + Specificity - 1) (Youden, 1950).
Studies on diagnostic accuracy need to have a group of people who are
healthy and a group of people who have a target condition as defined by a reference
standard. The index test is then used on both those with and those without the
condition with true positive, false positive, true negative, and false negative
determined with reference to the standard (Knottnerus & Muris, 2002).
Diagnostic Accuracy of the ACE-R and the ACE-III
The diagnostic accuracy of English versions of the ACE-R and the ACE-
III have been investigated in previous studies (Crawford, Whitnall, Robertson, &
Evans, 2012; Larner & Mitchell, 2014). Authors of a recently published meta-
analysis reviewed the clinical accuracy of the ACE and the ACE-R in detecting
people with or without dementia (Larner & Mitchell, 2014). The meta-analysis
included five studies on the ACE-R with a total of 560 cases of dementia out of a
sample of 1,156. The data from these studies show that 514 individuals out of 560
were positively identified using the ACE-R, which reflects 91.8% sensitivity.
Similarly, 383 individuals were correctly eliminated from a comparison sample of
596 to give 87.5% specificity. The reference standard for four of the five studies
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included in the meta-analysis was the Diagnostic and Statistical Manual (DSM) (usually
version IV) at given cutoffs.
In 2013, the updated version, the ACE-III was published (Hsieh et al.,
2013), improving on the weaknesses in certain domains in the ACE-R. To date,
there has been no published systematic review or meta-analysis on the clinical
utility and diagnostic accuracy of the ACE-III. During its evaluation, the ACE-III
was compared with standardised neuropsychological tests commonly used to assess
cognitive functioning, focusing on attention, language, memory, and others. A
comparison of the ACE-III with the ACE-R showed a significant level of
correlation (r = 0.99, p < 0.01). The ACE-III has also shown high sensitivity and
specificity at the recommended cutoff points, which are 88 cutoff (sensitivity = 1.0,
specificity = 0.96) and 82 cutoff (sensitivity = 0.93, specificity = 1.0) (Hsieh et al.,
2013).
Current Literature Review
The diagnostic accuracy of the English version of the ACE-R was
evaluated in a recently published systematic review (Crawford, Whitnall,
Robertson, & Evans, 2012) and in a meta-analysis (Larner & Mitchell, 2014).
However, no systematic review was identified that has specifically investigated the
literature on the clinical accuracy of the non-English versions of the ACE-R and
the ACE-III in diagnosing dementia, despite there being a number of published non-
English versions. In light of this, the aim of the current review is to review the
diagnostic accuracy of the non-English versions of the ACE-R and the ACE-III in
diagnosing dementia with reference to sensitivity, specificity, ROC curve and LR
and OR analysis.
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Methods
Search Strategy
The search was conducted in December 2015, which involved searching three
electronic databases: PsychINFO, MEDLINE, and EMBASE. The following search
words were used: Addenbrooke’s Cognitive Examination-Revised, Addenbrooke’s
Cognitive Examination- III, ACE-R, ACE-III, and foreign language translation.
Terms were combined using Boolean operators OR and AND. Because the ACE-R
and the ACE-III—published in 2006 and 2013, respectively—were updated
versions of the ACE (Mathuranath et al., 2000), only studies published from 2006
to the present were included in the search. Titles, abstracts, and full articles were
reviewed to assess their eligibility in light of the inclusion and exclusion criteria of
the current literature review. Reference lists of included studies were reviewed to
identify further articles.
Inclusion Criteria
1. Studies investigating the diagnostic accuracy of non-English versions of
the ACE-R and the ACE-III
2. If more than one study translated the ACE-R and the ACE-III to the same
language, all different versions were included
Exclusion Criteria
1. Studies not in English
2. Studies on the English versions of the ACE-R and the ACE-III
3. Studies that used non-English versions of the ACE-R or the ACE-III to
track changes in cognitive functioning over time rather than diagnostic
accuracy
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4. Studies that used non-English versions of the ACE-R or the ACE-III as
part of a wider cognitive assessment without providing information on the
screening tool
5. Abstracts, response letters, reviews and guides
Data Extraction
All eligible articles were read, and data were extracted on
demographic information such as gender, age in years, education in years as well
as reference standards used, cutoff scores, sensitivity, specificity, ROC curve, LR,
positive predictive value (PPV), negative predictive value (NPV), and the Youden
index.
Quality Assessment
The Standards for Reporting of Diagnostic Accuracy Studies (STARD)
checklist (Bossuyt et al., 2015) was used to assess the quality of the studies of
diagnostic accuracy. STARD is a 30-item checklist divided into sections that follow
the IMRAD (Introduction, Methods, Results, and Discussion) structure of scientific
papers. STARD was developed in 2003 and is widely used to evaluate the quality
of the studies on diagnostic accuracy (Bossuyt et al., 2003). The 2015 version is the
most recent update. A Score of two indicate that the information is well presented
and detailed, scores of one indicate that information is present but without adequate
details, and scores of 0 indicate the absence of information. The overall score is 62.
In line with the recommendations of National Institute for Clinical
Excellence (NICE, 2014), quality assessment consisted of critical appraisal and an
overall rating of high quality (++) indicating detailed and adequate information
was reported, medium quality (+) indicating information was reported but with
insufficient details or low quality (-)indicating information was not reported, with
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reference to STARD rating and critical appraisal of how likely identified issues
were to alter the conclusion of the study.
Results
Study Selection
Study selection involved systematic review of the available literature on
the translated versions of the ACE-R and the ACE-III. It resulted in 15 articles that
met the eligibility criteria. During the search process, 721 articles were initially
identified among the three databases that were searched: PsychINFO, MEDLINE,
and EMBASE. Figure 3 provides a flow chart of the systematic screening process.
Summary of Results
A summary of the study characteristics of all eligible studies is reported
in Table 1. It contains the diagnoses of participants, gender, age in years, and
education in years. It also includes the mean score of the ACE-R and the ACE-III
as the index test and lists all the reference gold-standard tests that were used to
identify participants with or without the target condition. Information about
diagnostic accuracy includes cutoff points, sensitivity, specificity, and the ROC
curve. LR, PPV, NPV, and the Youden index are shown in Table 2. Details about
the quality assessment and the critical appraisal of the included studies are reported
in Table 3.
20
Figure 3. Flowchart of search process.
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Table 1 Study Characteristics
Language Author
(year)
ACE-R/
ACE-III
Participants type Gender
male: female
Age in years
Mean ± SD
Years of Education
Mean ± SD
ACE-R/ACE-III
Mean ± SD
Brazilian (Carvalho
et al.,
2010)
ACE-R Alzheimer (n= 31)
Healthy (n= 62)
13:18
22:40
78.03 ± 6.74
77.82 ± 6.58
9.97 ± 5.19
10.05 ± 4.98
63.10 ± 10.22
83.63 ± 7.90
Brazilian (Sobreira
et al.,
2015)
ACE-R
Dementia (n= 17)
MCI (n= 32)
Healthy (n= 30)
3:13
16:15
10:20
72.5 (53-81)*
57 (37-77)
61 (28-79)
5.50 (2-18)*
10 (0-20)
4 (1-20)
67 (32-85)*
80 (41-98)
80.5 (53-95)
Chinese (Fang et
al., 2014)
ACE-R AD (n= 25)
MCI (n= 75)
Healthy (n= 51)
11:14
37:38
23:28
73.32 ± 8.13
69.52 ± 9.69
68.16 ± 8.18
9.68 ± 5.01
10.07 ± 4.41
11.77 ± 3.46
55.72 ± 9.20
76.56 ± 10.31
87.59 ± 7.68
Chinese (Wong et
al., 2013)
ACE-R Dementia (n= 54)
MCI (n= 50)
Healthy (n= 43)
19:35
21:29
21:29
79.2 ± 6.6
76.9 ± 7.3
72.8 ± 7.5
3.7± 4.2
4.2 ± 4.2
5.6± 4.3
50.8 ± 15.4
68.2 ± 15.7
86.4 ± 8.9
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Language Author
(year)
ACE-R/
ACE-III
Participants type Gender
male: female
Age in years
Mean ± SD
Years of Education
Mean ± SD
ACE-R/ACE-III
Mean ± SD
French (Bastide
et al.,
2012)
ACE-R Dementia (n= 128)
MCI (n= 118)
Healthy (n= 73)
47:81
47:71
17:56
75 ±11
72 ±9
68 ±11
18 ± 4
18 ± 4
20 ± 4
70 ± 10
83 ± 8
93 ± 4
German (Alexopo
ulos et al.,
2010)
ACE-R Alzheimer (n= 56)
(FTLD) (n= 22)
MCI (n= 75)
Healthy (n= 76)
20:36
13:9
45:30
29:47
72.00 ± 8.18
69.64 ± 6.18
67.83 ± 8.01
69.64 ± 7.53
11.02 ± 2.63
11.70 ± 3.52
12.00 ± 3.27
11.78 ± 2.51
64.80 ± 11.32
64.50 ± 17.82
81.34 ± 9.09
90.37 ± 4.99
Greek (Konstant
inopoulou
et al.,
2011)
ACE-R Alzheimer (n= 16)
FTD (n= 19)
Healthy (n= 60)
8: 8
6:13
30:30
71.69 ± 5.50
67.47 ± 6.87
66.20 ± 8.96
7.75 ± 3.98
9.89 ± 4.12
10.60 ± 4.22
55.63 ± 17.14
61.00 ± 17.82
89.13 ± 7.54
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Language Author
(year)
ACE-R/
ACE-III
Participants type Gender
male: female
Age in years
Mean ± SD
Years of Education
Mean ± SD
ACE-R/ACE-III
Mean ± SD
Italian (Pigliautil
e et al.,
2012)
ACE-R Young-old
Dementia (n= 40)
Healthy (n= 41)
old-old
Dementia (n= 67)
Healthy (n= 31)
16:24
18:23
25:42
11:20
70.8 ± 3.6
69.6 ± 2.8
80.9 ± 3.6
80.7 ± 3.6
7.1 ± 3.7
8.9 ± 4.6
7.1 ± 4.8
7.7 ± 3.9
63.3 ± 13.2
87.1 ± 9.3
53.6 ± 12.2
80.5 ± 10.7
Japanese (Kawata
et al.,
2012)
ACE-R Dementia (n= 126)
Healthy (n= 85)
34:92
34:51
77.3 ± 7.6
71.5 ±9.1
10.6 ± 2.5
12.3 ± 2.6
58.4 ± 16.4
90.8 ± 6.9
Japanese (Yoshida
et al.,
2012)
ACE-R Dementia (n= 130)
MCI (n= 39)
Healthy (n= 73)
42: 88
17: 22
27: 46
75.4 ± 7
71.4 ± 9.2
66.3 ± 10
11.1 ± 2.7
11.4 ± 2.1
12.7 ± 2.3
61.5 ± 12.9
82.2 ± 6.4
93.3 ± 3.9
Korean (Kwak et
al., 2010)
ACE-R Alzheimer (n= 30)
SIVD (n= 42)
Healthy (n= 84)
13:17
20:22
40:44
73.1 ± 11.2
70.1 ± 10.2
67.8 ± 9.3
8.9 ± 4.2
8.6 ± 3.9
10.1 ± 4.1
52.5 ± 15.1
53.2 ± 17.0
80.7 ± 6.0
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Language Author
(year)
ACE-R/
ACE-III
Participants type Gender
male: female
Age in years
Mean ± SD
Years of Education
Mean ± SD
ACE-R/ACE-III
Mean ± SD
Portuguese (Goncalve
s et al.,
2015)
ACE-R Subcortical
vascular dementia
(n= 18)
Alzheimer (n= 36)
Healthy (n= 38)
11:7
16:20
17:21
75.50 ± 5.29
75.14 ± 4.12
76.95 ± 6.92
3.22 ± 1.73
4.64 ± 3.16
5.61 ± 2.81
55.06 ± 9.19
55.53 ± 10.16
82.11 ± 1.29
Spanish (Raimond
i et al.,
2012)
ACE-R Alzheimer (n= 25)
VaD (n= 32)
Healthy (n= 26)
12:13
16:16
13:13
77.64 ± 5.3
75.59 ± 6.4
73.23 ± 8.9
14.48 ± 3.6
12.97 ± 4.3
14.46 ± 2.2
Spanish (Torralva
et al.,
2011)
ACE-R Alzheimer (n= 46)
bvFTD (n= 41)
Healthy (n= 40)
12: 34
9: 32
11: 29
73.4 ± 5.7
70.0 ± 9.3
71.5 ±5.6
12.9 ± 4.6
12.8 ± 5.1
13.0 ± 3.8
78.1 ± 9.4
64.2 ±16
94.3 ± 4.2
Spanish (Matias-
Guiu et
al., 2014)
ACE-III Dementia (n= 87)
Healthy (n= 130)
34:53
46:84
77.3 ± 8.4
71.0 ± 11.0
7.5 ± 4.6
9.8 ± 5.9
50.4 ± 16.0
81.8± 12.7
*Only the median (min-max) was reported in the article.
** Alzheimer disease (AD), Frontotemporal lobar degeneration (FTLD), Behavioural Variant Frontotemporal lobar degeneration (bvFTD),
Subcortical vascular dementia (SVD) and Subcortical Ischemic Vascular Dementia (SIVD).
**** A blank space indicates no information is available.
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Table 2 Diagnostic Accuracy and Quality Assessment
Language Author (year) Cutoff score Sensitivity Specificit
y
ROC curve STARD
score/number of
items
Main limitations Rating of
overall quality
Brazilian (Carvalho et al., 2010) 78 100 82.26 0.947 31/62 No sufficient details about the ACE-
R or rational for the cutoff point, non-
blind, time interval not stated,
indeterminate data was not reported,
power not calculated
_
Brazilian (Sobreira et al., 2015) 76 88 68 0.84 34/62 Non-blind, power not calculated,
indeterminate data was not reported,
_
Chinese (Fang et al.,2014) 67/68 92 86 0.945 33/62 Non-blind, indeterminate data was not
reported, power not calculated, time
interval not stated, poorly defined
sample
_
Chinese (Wong et al., 2013) 73/74 93 95 0.98 40/62 Indeterminate data was reported, time
interval not stated, poorly defined
sample
+
French (Bastide et al., 2012) 83/89 98 99 0.986 32/62 No rational for the cutoff point of the
reference standard, non-blind,
indeterminate data was not reported,
power not calculated, time interval not
stated, poorly defined sample
_
German (Alexopoulos et al.,
2010)
AD 82/83
FTLD 83/84
92
88
96
96
0.99
0.97
35/62 Power not calculated, indeterminate
data was not reported, no rational for
the cutoff point of ACE-R, time
interval not stated, poorly defined
sample
_
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Language Author (year) Cutoff score Sensitivity Specificit
y
ROC curve STARD
score/number of
items
Main limitations Rating of
overall quality
Greek (Konstantinopoulou
et al., 2011)
85
82
80
97
89
86
82
88
92
0.963 21/62 No rational for the cutoff point of
ACE-R or the reference standard, no
sufficient details about ACE-R,
indeterminate data was not reported,
non-blind, power not calculated, time
interval not stated
_
Italian (Pigliautile et al., 2012) Young-old
79
old-old 60
90
82
80
100
0.936
0.931
31/62 No rational for the cutoff point of
ACE-R or the reference standard, non-
blind, indeterminate data was not
reported, time interval not stated
_
Japanese (Kawata et al., 2012) 80 94 94 0.98 37/62 Poorly defined sample, no rational for
the cutoff point of ACE-R or the
reference standard, indeterminate data
was not reported, power not
calculated, time interval not stated
_
Japanese (Yoshida et al., 2012) 82/83 99 99 0.99 44/62 Power not calculated, indeterminate
data was not reported, no rational for
the cutoff point of ACE-R, time
interval not stated
+
Korean (Kwak et al., 2010) 78 93 95 35/62 Poorly defined sample, No rational for
the cutoff point of ACE-R or the
reference standard, indeterminate data
was not reported, power not
calculated, time interval not stated
_
Portuguese (Goncalves et al., 2015) SVD 72/73
AD 72/73
SVD 100
AD 97
SVD 97
AD 92
SVD 0.99
AD 0.98
34/62 No rational for the cutoff point of
ACE-R or the reference standard,
poorly define sample, indeterminate
data was not reported, time interval
not stated
+
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Language Author (year) Cutoff score Sensitivity Specificit
y
ROC curve STARD
score/number of
items
Main limitations Rating of
overall quality
Spanish (Raimondi et al., 2012) 88 100 100 1.0 31/62 Poorly defined sample, no rational for
the cutoff point of ACE-R, non-blind,
indeterminate data was not reported,
power not calculated, time interval not
stated
_
Spanish (Torralva et al., 2011) 85 97 88 32/62 Poorly defined sample, non-blind,
power not calculated, indeterminate
data was not reported, time interval
not stated
_
Spanish (Matias-Guiu et al.,
2014)
65.6 83 80 0.92 32/62 No rational for the cutoff point of
ACE-R or the reference standard, non-
blind, indeterminate data was not
reported, time interval not stated
_
*Alzheimer disease (AD), Frontotemporal lobar degeneration (FTLD), subcortical vascular dementia (SVD).
++ = High quality (detailed and adequate information was reported) + = medium quality (Information was reported but with insufficient details) and - = low
quality (Information was not reported)
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Description of Study Characteristics
The articles included in this review were the studies identified as papers
written in English on the topic of diagnostic accuracy of the translated versions of
the ACE-R and the ACE-III. The translated versions were in the following
languages: Brazilian, Chinese/ Mandarin, Chinese/Cantonese, French, German,
Greek, Italian, Japanese, Korean, Portuguese, and Spanish.
The clinical cutoff scores for the translated measures included in this
review ranged between 60 (Pigliautile et al., 2012) and 89 (Bastide et al., 2012).
The sensitivity of the measures to identify people with dementia ranged between
82% (Pigliautile et al., 2012) and 100% (Carvalho et al., 2010; Raimondi et al.,
2012). The specificity of the studies to distinguish people without dementia ranged
between 68% (Sobreira et al., 2015) and 100% (Pigliautile et al., 2012; Raimondi
et al., 2012).
The mean age of participants in the studies ranged between 66.20 ± 8.96
(Konstantinopoulou et al., 2011) and 80.9 ± 3.6 (Pigliautile et al., 2012). The years
of education ranged between 3.22 ± 1.73 and 20 ± 4 (Goncalves et al., 2015). The
types of dementia included across the studies were Alzheimer disease (AD),
Frontotemporal lobar degeneration (FTLD), Behavioural Variant Frontotemporal
lobar degeneration (bvFTD), and Subcortical vascular dementia (SVD) or
Subcortical Ischemic Vascular Dementia (SIVD).
Methodological Review of the Studies
The methodological review was completed in three steps. The first step
involved extracting the sensitivity and specificity data to evaluate the ability to
distinguish between people with or without dementia. The second step was to score
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the articles on the basis of the STARD criteria (Bossuyt et al., 2015). To investigate
how likely identified issues were to alter the conclusion of the study, the third step
was to assess the quality of the evidence on the basis of the critical appraisal and an
overall rating of high (++), medium (+), or low (-) quality (NICE, 2014) with
reference to the STARD rating criteria.
In the current review, 12 studies were judged to be of low (-) quality, and
three were judged to be of medium (+) quality. The discussion of the quality of the
studies is explained in the results section below. Common methodological problems
were identified during the critical appraisal of the studies, which influenced the
ability to draw evidence-based conclusions. In all 15 studies included in the current
review, no information was given on how indeterminate scores were handled. This
might have inflated or deflated the estimation of the diagnostic accuracy if data
occurred more frequently in either people with or people without dementia (Bossuyt
et al., 2003). There was also no indication of the time interval between the index
and the reference tests in 14 studies; consequently, there may have been changes in
the target condition over time that might have influenced the diagnostic accuracy
of the measure (Bossuyt et al., 2003). In 11 studies, insufficient information was
given about either the index test or the reference standard that could inform the
reader about the definition of the target condition and different diagnostic strategies
(Bossuyt et al., 2003). The power calculation indicating the intended sample size
was not reported in 11 studies, despite the importance of determining the sample
size needed to identify clinically relevant findings (Machin, Campbell, Fayers, &
Pinol, 1997). Furthermore, nine studies did not include information on the sampling
process of participants; thus, it was difficult to assess the population for whom the
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study was generalisable (Konttnerus & Muris, 2002). Similarly, in nine studies,
assessors were not blind to clinical information, meaning that researchers were
aware of the clinical diagnosis of the participants while administrating the ACE-R
or the ACE-III. Non-blindness might mean that more people were accurately
diagnosed because assessors already knew who had dementia, which might have
influenced the administration and scoring of the screening test (Philbrick, Horwitz,
& Feinstein, 1980).
Results of Individual Studies Categorised by the Language of Translation
Brazilian Translation. In two of the studies, the diagnostic accuracy of the
Brazilian translation of the ACE-R was assessed for its ability to detect dementia.
The findings from the first study (Carvalho et al., 2010) suggested that sensitivity
for the ACE-R was 100% and that specificity was 82.26%, indicating excellent
ability to detect dementia. A clear description was given for the clinical
characteristics of participants so that the reader was informed about the feasibility
and the generalisability of the findings (Bossuyt et al., 2003). The reference
standards were clinical gold standards for the assessment of dementia, and the
rationale for choosing the reference standard was given. However, there was
insufficient information about the administration of the ACE-R and the rationale
for the cutoff score. Similarly, information was not provided on the blindness of the
assessors to the clinical information or the time interval between the clinical
assessment and the administration of the ACE-R. In addition, the authors of the
study did not report the power calculation or sampling process. It was not clear how
the indeterminate data was handled. In view of the appraisal, the conclusion
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regarding the diagnostic accuracy of the measure as a tool to distinguish between
people with or without dementia was compromised, as the study was of low quality.
The findings from the second article on the Brazilian translation of the ACE-
R (Sobreira et al., 2015) indicated good ability in distinguishing between people
with or without dementia among those who had Parkinson’s disease (sensitivity =
88%, specificity = 68%). A coherent clinical rationale was provided with clear
objectives and hypotheses, which allowed the reader to evaluate the analysis and
the results (Bossuyt et al., 2003). Information was given on the index test and the
reference standard that could assist the reader to have an informed interpretation of
the diagnostic accuracy estimates (Konttnerus & Muris, 2002). However, the
assessors were not blind to the clinical information, and the authors did not indicate
how indeterminate scores were handled. Similarly, the authors did not report the
power calculation and how the sample size was determined. Taking into account
the sensitivity and specificity of the current measure, together with the quality of
information reported, the study was assessed as low quality and the authors
conclusions about sensitivity and specificity were likely compromised.
Chinese Translation. Two of the studies were on the diagnostic accuracy of
the Chinese translation of the ACE-R. The first article was an investigation of the
diagnostic accuracy of the Chinese (Mandarin) translation of the ACE-R (Fang et
al., 2013) in diagnosing dementia. The results suggested that the ACE-R was an
excellent tool (sensitivity = 92%, specificity = 86%) for distinguishing between
people with or without the target condition. Sufficient information was given about
the study objectives and hypotheses and the clinical background of the index test,
which would allow replication (Konttnerus & Muris, 2002). In addition,
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information was provided about the index and the reference standards, the baseline
demographics of participants, and eligibility criteria, which could inform the reader
about the generalisability of the findings (Bossuyt et al., 2003). However, no
information was given on how indeterminate results of either tests were handled.
Furthermore, assessors were not blind to the clinical information, and the time gap
between both measurements was not specified. In addition, the sampling was poorly
defined, and the power calculation was not conducted. The validity of the study to
draw conclusions about sensitivity and specificity was likely compromised because
the study was considered of low quality.
The second article was a report on the diagnostic accuracy of the Chinese
(Cantonese) translation of the ACE-R (Wong et al., 2013). The results indicated an
excellent ability of the ACE-R as a tool to distinguish between people with or
without dementia (sensitivity = 93%, specificity = 95%). Taking into consideration
the checklist items of STARD, the authors of the study provided sufficient details
on the index test to allow replication, and gold-standard reference tests were used
that were consistent with the literature. To minimise the risk of bias, a researcher
blind to the clinical information of all participants administered the index test
(Cantonese ACE-R) within a week of the clinical assessment. However, the sample
of the study was poorly defined, and the study’s authors did not indicate how
indeterminate data were handled. Similarly, no information was given on the time
interval between the reference standard and the ACE-R. Therefore, the validity of
the study for drawing a conclusion about sensitivity and specificity was slightly
compromised, as the study was of medium quality.
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French Translation. One published paper was a retrospective study on the
diagnostic accuracy of the French version of the ACE-R (Bastide et al., 2012). The
sensitivity of the test was 98%, and the specificity was 99%, suggesting that the test
is an excellent tool to identify those who have dementia and those who do not. The
STARD appraisal checklist indicated that detailed information was given about the
index test and the reference standard, which provided a clear rationale for the testing
procedure and would allow replication. However, the authors did not indicate
blindness of the assessors to the clinical information when administering and
scoring the ACE-R or indicate the time interval between both measures. Similarly,
sampling was poorly defined, and power was not calculated. Therefore, the study
was of low quality, and the ability to draw a conclusion of excellent sensitivity and
specificity was likely compromised.
German Translation. The study on the German translation of the ACE-R
(Alexopoulos et al., 2010) was an investigation of the diagnostic accuracy of the
translated screening tool. The results of the study suggested that the measure could
be used to discriminate between people with or without dementia: Alzheimer’s
disease (sensitivity = 92%, specificity = 96%) and frontotemporal lobar
degeneration (sensitivity = 88%, specificity = 96%). However, the sample was
poorly defined; no indication of the power calculation was included, and no
information was provided on how indeterminate data were handled. Furthermore,
the authors did not give the time interval between the index and the reference tests
or explain the rationale of the cutoff point of the ACE-R. Therefore, the study was
of low quality, and the ability of the authors to draw a conclusion about sensitivity
and specificity was likely to be compromised.
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Greek Translation. The article on the Greek translation of the ACE-R
(Konstantinopoulou et al., 2011) was an investigation of the diagnostic accuracy of
the Greek ACE-R in detecting different types of dementia. The findings from this
study suggested that the ACE-R was used to detect those with or without dementia
(sensitivity ranged from 86% to 97%; specificity ranged from 82% to 92%). A clear
description was given on the clinical background of the index test, objectives, and
hypotheses—eligibility criteria that provided clear information on the design of the
study that would help the reader to interpret the results and replicate the study
(Bossuyt et al., 2003). However, there was no sufficient information on the
administration of the ACE-R or the definition of the cutoff points. Similarly, no
information was given on the assessors’ blindness to the clinical information or the
time interval between measures. In addition, there was also no indication of the
power calculation or how indeterminate scores were handled. In light of that, the
study was determined to be of low quality, and the ability of the authors to draw a
conclusion on the diagnostic accuracy of the measure was likely compromised.
Italian Translation. Although few articles included examinations of the
Italian versions of the ACE-R, one article (Pigliautile et al., 2012) met the inclusion
criteria of the current review. The aim of that study was to evaluate the diagnostic
accuracy of the translated measure on young-old adults and old-old adults with or
without dementia. The findings from the study were a sensitivity of 90% and a
specificity of 80% for young-old adults and a sensitivity of 82% and a specificity
of 100% for old-old adults, demonstrating excellent ability of the ACE-R as a tool
to distinguish between people with or without dementia. A clear description was
given for the clinical characteristics of participants that informed the reader about
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the feasibility and the generalisability of the findings (Bossuyt et al., 2003).
However, the assessors were not blind to the clinical information, and the authors
did not report the time interval between the clinical assessment and the
administration of the ACE-R. Similarly, there was no clear rationale given for the
cutoff point of the ACE-R or how indeterminate scores were handled. In view of
the appraisal, the study was determined to be of low quality, and the ability of the
authors to draw a conclusion of excellent sensitivity and specificity was likely
compromised.
Japanese Translation. In two studies, the authors investigated the diagnostic
accuracy of the Japanese translation of the ACE-R in diagnosing dementia. The
results of the first article (Kawata et al., 2012) suggested that the ACE-R is an
excellent tool to identify people with dementia (sensitivity = 94%, specificity =
94%). In terms of an appraisal based on STARD criteria, sufficient information was
given on the index test and the reference standard, which provided the reader with
the clinical information that could assist the reader in estimating the accuracy of the
results (Konttnerus & Muris, 2002). Compared to other studies, the clinical
assessment in this study was conducted independently from the administration of
the ACE-R to avoid a potential risk of biasing the scores. However, the study poorly
defined the sampling process and did not provide power calculation of the estimated
sample size. Likewise, there was no information on the rationale of the cutoff point
of the ACE-R or the reference standard. Therefore, the study was of medium
quality, and the ability of the authors to draw a conclusion about the sensitivity and
specificity was slightly compromised.
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Authors of the second article (Yoshida et al., 2012) also investigated the
diagnostic accuracy of the Japanese translation of the ACE-R. The results indicated
that the ACE-R was excellent in distinguishing between people with or without
dementia (sensitivity = 99%, specificity = 99%). In light of a STARD-based
appraisal, sufficient information was given about the index test and the reference
standard that could inform the reader about the target condition and how it was
defined and categorised (Konttnerus & Muris, 2002). Similar to the other Japanese
translation (Kawata et al., 2012), the clinical assessment was independently
conducted from administering the ACE-R, meaning that assessors were blind to the
reference standard to minimise any possible source of bias (Philbrick et al., 1980).
However, the authors did not report the rationale for the cutoff point of the ACE-
R. Neither did they indicate the estimated sample size based on the power
calculation. The time interval between the reference standard and the ACE-R was
not reported. Furthermore, there was no information on how the authors dealt with
the indeterminate scores. Therefore, the conclusion regarding the diagnostic
accuracy of the measure as a tool to distinguish between people with or without
dementia was compromised, as the study was of low quality.
Korean Translation. One article was published on the diagnostic accuracy
of the Korean translation of the ACE-R (Kwak et al., 2010). The authors focused
on investigating the ACE-R for its use in detecting dementia and to differentiate
between Alzheimer’s disease and subcortical ischemic vascular dementia. The
findings from the study suggested that the Korean translation of the measure had
93% sensitivity to detect people with dementia and 95% specificity to detect people
without dementia, suggesting an excellent diagnostic accuracy. However, there was
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no clear definition of the cutoff or the rationale for the reference test. Similarly, no
information was given on the sampling process or power calculation. The authors
did not indicate the time interval between measures or how they dealt with
indeterminate scores. Therefore, the study was of low quality, and the ability of the
study to provide a conclusion of excellent diagnostic accuracy was compromised.
Portuguese Translation. In one published paper, Goncalves et al. (2015)
reported on their examination of the diagnostic accuracy of the translated version
of the ACE-R to Portuguese. The findings from that study generally suggested that
the ACE-R was used to detect those with Alzheimer’s disease (sensitivity = 100%,
specificity = 97%) or subcortical vascular dementia (sensitivity = 97%, specificity
= 92%). However, a STARD criteria appraisal of the study revealed that no
information was given about the rationale for the cutoff point of the ACE-R and the
reference standard. Similarly, there was no information given on the time interval
between the index and reference standard measures. In addition, no information was
available on the sampling process or how indeterminate scores were handled.
Therefore, despite the evidence of sensitivity and specificity, the study was of
medium quality, and the ability of the study to draw a conclusion about the
diagnostic accuracy was slightly compromised.
Spanish Translation. Two articles were identified on the diagnostic
accuracy of the Spanish translation of the ACE-R, and one article was an
examination of the diagnostic accuracy of the Spanish version of the ACE-III. In
the first article on the Spanish ACE-R (Raimondi et al., 2012), people who had
Alzheimer’s disease or subcortical ischemic vascular dementia were compared with
healthy individuals who participated as study controls. The results suggested that
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the ACE-R is an excellent tool to discriminate between people with or without
dementia (sensitivity = 100%, specificity = 100%). In terms of a STARD criteria
appraisal, the sampling process was poorly defined, and the estimated sample size
based on the power calculation was not reported. Furthermore, there was no
rationale for the cutoff point of the ACE-R, and the indeterminate data were not
defined. In addition, assessors were not blind to clinical information, and the time
interval between the measurements was not reported. Despite the evidence of the
diagnostic accuracy, the validity of the study to draw a conclusion about sensitivity
and specificity was compromised in light of the low quality of the study.
In the second article, the diagnostic accuracy of the Spanish translation
of the ACE-R was also examined, with the study population being Argentinian
(Torralva et al., 2011). The study population included people who were healthy
individuals (study controls), people with Alzheimer’s disease, and people
diagnosed as having a behavioural variant of frontotemporal dementia. The findings
from the study suggested that the ACE-R is an excellent tool to use to discriminate
between people with or without dementia (sensitivity = 97%, specificity = 88%).
However, the critical appraisal showed that the sampling process was poorly
defined and that the power was not calculated. Furthermore, assessors were not
blind to the clinical information when administering the ACE-R, and the time
interval between measures was not stated. In view of the above, the study was of
low quality, and the conclusion regarding the diagnostic accuracy of the test was
likely compromised.
The third article (Matias-Guiu et al., 2014) was on the diagnostic
accuracy of the Spanish translation of the ACE-III, the only translated version of
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the ACE-III that met all of the inclusion criteria of the current review. The results
of that article suggested that the ACE-III is a good tool that can be used to
distinguish between people with or without dementia (sensitivity = 83%, specificity
= 80%). A coherent clinical rationale was provided with clear objectives and
hypotheses, which allowed the reader to evaluate the analysis and the results. There
was also a clear description of the clinical characteristics of participants that would
allow the reader to judge the generalisability of the findings (Bossuyt et al., 2003).
However, the authors did not state the rationale for the cutoff point of the ACE-R
or the reference standard. The assessors were not blind to the clinical information,
and the time interval between both measures was not clear. The authors did not
report how the indeterminate scores were handled. In light of the above, the study
was of low quality, and ability of the study to draw a conclusion about the
sensitivity and specificity was likely compromised.
Discussion
The ACE-R and the ACE-III are screening tools designed to detect
dementia as part of a wider comprehensive clinical assessment. The ACE-R and the
ACE-III have been translated to different languages and adapted to diverse cultures.
Fifteen translated papers met the inclusion criteria and were included in the review.
The aim of the current review was to investigate the diagnostic accuracy of the
translated versions of the ACE-R and the ACE-III in detecting dementia.
Summary of the Results
The diagnostic accuracy assessed through the sensitivity and specificity
of the studies included in the current review revealed the measures’ ability to
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discriminate between people with or without dementia. The sensitivity ranged
between 82% (Pigliautile et al., 2011) and 100% (Carvalho et al., 2010; Raimondi
et al., 2012). The specificity ranged between 68% (Sobreira et al., 2015) and 100%
(Pigliautile et al., 2011; Raimondi et al., 2012). However, the critical appraisal of
the studies suggested that the conclusion of excellent sensitivity and specificity
might have been compromised due to biases in study design.
General Methodological and Conceptual Issues
Sensitivity and specificity of all screening tools were reported, but the
other measures of diagnostic accuracy used to discriminate between people with or
without the target condition were rarely reported. The LR was stated in only two
studies: the Spanish translation of the ACE-R (Torralva et al., 2011) and the Korean
translation of the ACE-R (Kwak et al., 2010). Similarly, the PPV and the NPV were
reported in only two studies: the Greek translation of the ACE-R
(Konstantinopoulou et al., 2011) and the Brazilian translation of the ACE-R
(Carvalho et al., 2010). The LR, PPV, and NPV could be used in future research as
other measures of diagnostic accuracy to provide the reader with other confirming
information on the diagnostic accuracy.
Overall, the evidence of diagnostic accuracy was positive, but valid
conclusions could not be confirmed because of bias risk as a result of some
methodological issues. There were common methodological problems that affected
the quality of the included studies. First, there was insufficient information given
about the index test and the reference standard that could inform the reader about
the definition of the target condition and different diagnostic strategies. Second,
there was no information available on the sampling process, intended sample size,
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or flowchart of participants that could reflect the recruitment process and allow the
reader to assess the population to whom the study was generalisable. Third, there
was no information given on how missing data and indeterminate scores were
handled. That might have inflated or deflated the estimation of the diagnostic
accuracy if those data occurred more frequently in either people with or without
dementia. Fourth, assessors were not blind to the clinical information in some
studies, meaning that more people were accurately diagnosed because assessors
already knew who had dementia which might have influenced the administration
and scoring of the ACE. Finally, there was no indication of the time interval
between the index and the reference tests, indicating possible changes in the target
condition over time that might have influenced the diagnostic accuracy of the
measure.
To be up to standard, screening tools must be able to detect people with
or without the target condition. It was interesting to observe the diverse cutoff
points of the translated versions of the ACE-R and the ACE-III across the range of
populations. The cutoff scores ranged from 65.5 in the Spanish translation of the
ACE-III up to 89 in the French translation of the ACE-R (Bastide et al., 2012). The
variation of the cutoff points could be due to differences in mean age and years of
education of participants. For example, the mean age and years of education of
healthy controls and people with dementia in the Spanish ACE-III (Matias-Guiu et
al., 2014) were different from the mean age and years of education of people in the
French ACE-R (Bastide et al., 2012). Years of education were less and the mean
age was higher in the Spanish study.
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Issues to Consider for Translation and Cultural Adaptation
The current review did not report the cultural and language adaptation of
the translated ACE-R and ACE-III because of the limited reporting of those
information in the articles. The guidance of evaluating the cross-cultural validity of
a measure (Mokkink et al., 2012) indicated adequate description of the original and
translating languages of the screening tool. It also involved detailed information on
the expertise of the translators in both languages and constructs. Detailed
description of the process of translation including independent forward and
backward translations and explanation of any discrepancies between the original
article and the translation. In addition, it involved reporting on the reviewing
process by a committee and the pre-testing to check cultural relevance and
coherence.
A previous study comparing between ACE-R and Mini Mental State
Examination (MMSE) in estimating cognitive functioning in people with
Alzheimer's disease suggested a high statistical correlation between the scores of
both screening tools (Law et al, 2013). It might be that MMSE would be a more
advantageous tool if translated from English because of its length and the nature of
the items.
Clinical and Research Implications
In light of the need to allow access to dementia care for those who do not
speak English, ACE-R and ACE-II have been translated into a number of
languages, but no review has examined the diagnostic accuracy of these non-
English version. Researchers and clinicians can refer to the current review to look
up the cut-off points and the diagnostic accuracy when they screen non-English—
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speaking individuals for dementia. However, on the basis of the current review,
they are advised to take into account that the diagnostic accuracy of the measures
might have been inflated or deflated due to the methodological issues mentioned.
Limitations of the Current Review
A main limitation identified in the current systematic review was in relation
to evaluating the translated versions of ACE-R. A previous study suggested that
ACE-R was clinically outdated and not used in clinical practice due to licensing
issues. Therefore, ACE-III was developed and have been clinically used (Hsieh et
al., 2013). There were also some limitations in the review process, which might
have led to systematic bias. Thorough assessment of the identified articles against
inclusion and exclusion criteria was carried out by the researcher alone. Although
the supervisor was consulted in relation to queries to any missing articles, that was
a limitation that might have produced bias. Similar limitations apply to quality
assessment of articles. Additionally, some articles relating to diagnostic accuracy
(N=4) were excluded because they were not in English due to a language barrier,
which could have provided clinicians and researchers with a wider selection of
translations. The excluded studies were in Czech (Bartoš et al., 2011; Berankova et
al., 2015), Turkish (Mihci et al., 2011), and Spanish (Munoz-Neira et al., 2012).
That meant no studies looking at Turkish, Czech and Chilean Spanish language
were included in the current review. Another limitation was that the cultural
adaptation of the measures was not evaluated and so it was not clear if the translated
versions were an adequate reflection of the original version (Mokkink et al., 2012).
There was a lack of detailed information on the translation and cultural adaptation
process. Given that the studies were on the diagnostic accuracy of translated
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measures, it was of particular importance to investigate the cultural validity of the
measures.
Areas for Future Research
The ACE-III was published in 2013, so there were only three published
translations for this version: a Spanish translation (Matias-Guiu et al., 2015), an
Egyptian-Arabic translation (Qassem et al., 2015), and a Portuguese translation
(Machado et al., 2015). The current review included only the Spanish translation of
the ACE-III (Matias-Guiu et al., 2015) because the other two translations were on
normative data. Future research could focus on the translated versions of the ACE-
III (Hsieh et al., 2013). Another future review could be on the original English
version of the ACE-III. Because of the recent year of publication, only a few studies
included the psychometric properties and the diagnostic accuracy of the English
ACE-III.
Conclusion
The current literature review revealed that the non-English versions of
the ACE-R and the ACE-III were useful diagnostic tools in detecting dementia.
However, the quality assessment suggested that included studies were of low to
medium quality, which indicated that the positive conclusions of the diagnostic
accuracy were likely to be compromised.
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Part 2: Empirical Paper
The Effect of Age on the Underlying Abilities of Mindfulness Practice
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Abstract
Introduction: Cognitive control and acceptance are considered as two key
underlying processes of mindfulness practice. Recent evidence has shown that
increasing age is related to a decline in cognitive control and the enhancement of
emotional regulation and, consequently, acceptance. However, the effect of age on
both underlying processes has not been investigated within a sample of older adults
and younger adults using clinically relevant measures.
Aims: To determine whether there is a difference in performance between an older
adult group and a younger adult group on measures of the cognitive
control/awareness and emotion regulation/acceptance elements of mindfulness. It
hypothesised that older adult would perform worse that younger adults on measures
of cognitive control and better on measure of emotion regulation/ acceptance.
Design: Cross-sectional between-groups design with one older adult group and one
younger adult group. Measures were administrated in a face-to-face research
interview. A total of 55 older healthy adults aged 65+ (M=72.5) and 55 younger
healthy adults aged 18-25 (M= 21.30) were recruited from the community for
participation.
Results: The results revealed that older adults performed better in mindfulness
measures of cognitive control/awareness whereas younger adults performed better
in mindfulness measures of emotion regulation/acceptance.
Conclusion: Age might compromise the underlying processes of mindfulness
practice. The results were discussed in light of available literature and with
reference to limitations and clinical implications.
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Introduction
Mindfulness is conceptualised as the process of directing attention to the
present experience (Kabat-Zinn, 1990) by enhancing the state of self-awareness
(Brown & Ryan, 2003) and acceptance (Bishop et al., 2004). It creates a skilled
position of acknowledging thoughts and emotions and assuming an observer’s
viewpoint of internal and external events (Wells, 2006). A growing body of
evidence exists for mindfulness-based psychotherapies in reducing anxiety and
depression (Hofmann, Sawyer, Witt, & Oh, 2010). Unlike cognitive behavioural
therapy, mindfulness consists of a nonjudgmental approach to worrying or
depressing thoughts rather than attempting to reappraise them. It is hypothesised
that this nonjudgmental and accepting stance leads to improvement in depressive
or anxious symptoms (Carmody, 2009).
Authors of previous studies suggest two key underlying processes of
mindfulness practice: cognitive control/awareness (Teasdale, Segal, & Williams,
1995) and emotion regulation/acceptance (Bishop et al., 2004). However, little is
known about the interaction between age and these underlying processes of
mindfulness-based psychotherapies (Prakash, De Leon, Patterson, Schirda, &
Janssen, 2014). The effect of age on these processes can inform the clinical
approach used with clients from different age groups. It can also help in
understanding any particular difficulties across life groups in compliance with
mindfulness practice, hence enriching the formulation, tailoring the treatment plan,
and the modifying the therapeutic goals.
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Cognitive Control and Mindfulness
Although there are a number of reviews focusing on cognitive control
(Park et al., 2002; Prakash et al., 2014; Salthouse, 2010), there seems to be no
explicit definition of the construct. On the basis of available studies, cognitive
control refers to cognitive processes that include four main components: working
memory, response inhibition (Niendam et al., 2012), response selection, and task
switching (Morton, Ezekiel, & Wilk, 2010). Response selection refers to the
cognitive process during which a stimulus presents and a particular response is
decided (Niendam et al., 2012) while response inhibition involves the inhibition of
any process or response to an internal or external stimulus (Morton, Ezekiel, &
Wilk, 2010). Cognitive control allows people to switch between different tasks,
which requires a level of cognitive flexibility (Dreisbach, 2012).
The exploration of the concept of cognitive control in relation to
mindfulness practice has increased, as cognitive control is considered one of the
key components underlying mindfulness-based psychotherapies (Teasdale et al.,
1995). Cognitive control is linked to the ability to ignore distracting stimuli, thereby
maintaining the focus of attention (Dreisbach, 2012) during mindfulness practice.
As such, cognitive control is a crucial component of the awareness aspect of
mindfulness-based psychotherapy (Bishop et al., 2004; Chiesa et al., 2011; Kabat-
Zinn, 1994; Lee & Orsillo, 2014).
Ageing and Cognitive Control
Previous studies suggest that age-related decline in neurocognitive
functioning affects cognitive control. The results of a longitudinal study on the
effect of age on executive functions show age-related decline in some
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neurocognitive processes involved in cognitive control such as task switching and
inhibition (Goh, An, & Resnick, 2012). A separate body of literature argues that
there is an age-related diffusion between relevant and irrelevant stimulus in
attention processing. In fact, older adults show better memory of external irrelevant
stimuli than younger adults. Older adults are also found to over-process distracting
stimuli when they occur (Gazzaley, Cooney, Rissman, & D’Esposito, 2005). It is
not just that older adults are less able to attend to relevant stimuli, but that,
compared to younger adults, the older adults process more and remember more
task-irrelevant stimuli.
Emotion Regulation and Mindfulness
A key component of mindfulness practice is accepting emotions as they
occur by taking a nonjudgmental position that allows a full emotional experience
(Baer, 2010). Mindfulness involves a state of openness, curiosity, and acceptance
of the emotional experiences. During mindfulness practice, people are encouraged
to connect with and acknowledge unpleasant feelings such as anxiety or pain rather
than avoiding or suppressing them (Hofmann & Asmundson, 2008).
All thoughts and feelings are perceived as an object of observation rather
than a disruption. As those feelings and thoughts emerge during mindfulness
practice, instruction is given to acknowledge their presence without any form of
judgment of the quality of the emotional object (Bishop et al., 2004). As such, it
requires staying with any feelings that might unfold during the process. This ability
to sit with feelings has been defined as an important emotional regulation strategy,
in which emotion regulation is the overarching term for a number of strategies used
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to dampen down/enhance emotional responses to events, suggesting a direct link
between mindfulness and emotional regulation (Farb et al., 2010).
Ageing and Emotion Regulation
A separate body of literature has concluded that emotional regulation as
a whole is enhanced as we age (Carstensen, 1993, 2006). An age-related
enhancement in the state of emotion regulation in older adults is well grounded in
literature (Prakash et al., 2014). Regarding the theory of socioemotional selectivity,
Carstensen (1993, 2006) argues that older adults’ preference toward positive rather
than negative emotions is explained by the change in goal orientation related to
their perception of life. With advanced age comes the realisation of limited time left
as life proceeds, and thus, the goal of emotion satisfaction becomes a priority over
future-oriented goals in younger age. This shift in emotion orientation, leads older
adults to selectively attend to positive emotions (Isaacowitz, Wadlinger, Goren, &
Wilson, 2006).
The results of a cross-sectional study investigating the developmental
course of emotional experience through adulthood indicate a positive association
between ageing and emotional well-being and stability (Carstensen et al., 2011).
Similarly, the findings of another cross-sectional study on the emotional experience
in older, middle-aged, and younger adults suggest a higher level of emotional
control, mood stability, and emotional maturity in older adults compared with the
findings regarding the other groups. This result is consistent with the assumption of
increasing self-regulatory capacity with age (Lawton, Kleban, Rajagopal, & Dean,
1992).
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The Current Study
As noted previously, cognitive control and aspects of emotion regulation,
particularly acceptance, are considered to be two key underlying processes of
mindfulness. Several researchers have concluded that increasing age is related to a
decline in cognitive control and the enhancement of emotion regulation, including
acceptance (Prakash et al., 2014). However, the interactions between age and both
underlying processes have not been investigated using clinically relevant measures
that involve a sample of older adults and younger adults. Accordingly, it is
hypothesised in the current study that performance on measures of cognitive control
in regards to mindfulness will be worse in older adults than younger adults, whereas
performance on a measure of acceptance aspects of mindfulness will be better in
older adults than younger adults.
Research Questions and Hypotheses
1. Is there a difference in performance between an older adult group and a
younger adult group in cognitive control elements of mindfulness as
measured using the Meditation Breath Attention Score (MBAS) and the
awareness sub-scale of the Philadelphia Mindfulness Scale (PHLMS)? It is
tentatively predicted that performance on both of these measures will be
worse in an older adult sample than a younger one.
2. Is there a difference between an older adult group and a younger adult group
on the acceptance/nonjudgment element of mindfulness assessed by the
acceptance/nonjudgmental sub-scale of the Philadelphia Mindfulness Scale
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(PHLMS)? It is tentatively predicted that performance on this measure will
be better in an older adult sample than a younger adult group.
3. If there is an age-related difference indicated in the MBAS, is that difference
associated with changes in cognitive flexibility? It is tentatively hypothesised
that if there is a difference between older and younger adults on the MBAS
score, it will be mediated by cognitive flexibility (measured by difference
score on the trail-making test [TMT]).
Methods
Design
Cross-sectional between-groups design with one older adult group, one
younger adult group, and two dependent variables.
Participants
The participants in this study were healthy older adults aged 65+ and
healthy younger adults aged 18 to 25.
Eligibility Criteria
Apart from the specified age range, the following criteria determined the
eligibility to participate in the current study were assessed through self-report in a
screening by telephone or e-mail.
1. Inclusion Criteria
Native speakers or people with high proficiency in English, doing a university
degree in the English language.
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2. Exclusion Criteria
• significant sensory impairment,
• learning disability,
• severe mental health problems identified by self-reported contact with mental
health services,
• self-reported previous experience of meditation or mindfulness practice, and
• possible dementia (indicated by scores below the threshold for dementia on
Addenbrooke’s Cognitive Examination, third edition [ACE-III], which is 82).
Setting
The younger adult sample consisted of University College London
(UCL) students and other younger adults who registered at the Psychology subject-
pool website for recruitment. The older adult sample was recruited via The
University of the Third Age, which was developed for retired and semi-retired
people who are keen to learn new skills. The older adults were also recruited from
Age UK, which is a charity organisation for older adults. They were invited to take
part in the current study through e-mails, posters, and leaflets. Snowball sampling
was also used by asking participants to recommend people who might be interested
or to pass out information to others.
Ethics
Ethical approval for this study was obtained after the review of the
research committee in the Clinical, Educational and Health Psychology Department
in University College London. The Ethics Approval reference number is
CEHP2015531 (see Appendix A).
62
Sample Size
G*Power version 3.0.10 was used to perform power analysis for two-
tailed independent t tests for a medium effect size. A medium effect size for
cognitive control and acceptance/non-judgment was of interest because this would
be a difference that would have clinical relevance. The estimated number of
participants was 51 older adults and 51 younger adults, based on Cohen’s d = 0.5
and β = 0.8. 
Measures
Demographic information. Participants self-reported age, gender,
marital status, ethnicity, years of education, and current or history of physical or
mental health issues.
Addenbrooke’s Cognitive Examination, third edition (ACE-III).
This measure was used in accordance with Hsieh, Schubert, Hoon, Mioshi, and
Hodges (2013). The ACE-III is a brief cognitive test that measures attention,
memory, verbal fluency, language, and visuospatial abilities. It has a high level of
validity as it shows a significant correlation with a number of standardised
neuropsychological measures such as WAIS-DS, RAVLT, SYDBAT, and others.
It has been validated on healthy controls and on patients with diagnoses of dementia
(Hsieh et al., 2013; Jubb & Evans, 2015) and has a high level of sensitivity and
specificity in detecting dementia. It also shows a high level of internal reliability as
measured by Cronbach’s coefficient =0.88 (Hsieh et al., 2013). The ACE-III was
used with all participants, but the main purpose was to use it with older adults after
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consent as a screening tool to assess their eligibility to participate in the current
study.
Meditation Breath Attention Score (MBAS). This measure was used
in accordance with the methods used in several studies (Frewen, Evans, Maraj,
Dozois, & Partridge, 2008; Frewen, Unholzer, Logie-Hagan, & MacKinley, 2014;
Lai, MacNeil, & Frewen, 2015; Logie & Frewen, 2015). MBAS is an experience–
sampling measure (Larson & Csikszentmihalyi, 1983), which assesses the level to
which participants are able to do the awareness aspect of mindfulness and its
components during a live experience (Frewen et al., 2008). It has high face and
construct validity as a measure of attentional awareness of mindfulness (Frewen et
al., 2014). It has been used in a naïve sample without previous meditation
experience (Liu et al., 2013).
Participants were instructed to complete a mindfulness exercise during
which they focused their attention on their breathing for two minutes. Then, they
carried on with the exercise for 15 minutes during which the instructor rang a bell
every 3 minutes. When the instructor rang the bell, the participants gave a signal
that their attention was maintained on their breathing. The instructor counted the
number of signals they received from the participants on a scale from 0 to 5.
The Philadelphia Mindfulness Scale (PHLMS). This measure was
used in accordance with Cardaciotto, Herbert, Forman, Moitra, and Farrow (2008).
This is a 20-item scale used to measure awareness and acceptance independently.
The internal consistency is good (Cronbach’s alpha for the awareness scale = 0.82
and for acceptance = 0.75) (Cardaciotto et al., 2008). Concurrent validity was
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demonstrated through strong correlations of sub-scales with the Kentucky
Inventory of Mindfulness Skills (KIMS) (Park, Reilly-Spong, & Gross, 2013).
Trail-Making Test (TMT). This measure was used in accordance with
Partington & Leiter (1949). This measure was used in the study to assess cognitive
flexibility. This is a neuropsychological test that measures visual attention and task
switching. It is used to assess speed of processing (Lezak, 1995), complex visual
scanning (Shum, McFarland, & Bain, 1990), and executive functioning and
cognitive flexibility (Gaudino, Geisler, & Squires, 1995). It consists of two parts:
A (numbers) and B (numbers and letters). Discrepancy scores between A and B are
important in assessing cognitive flexibility (Tombaugh, 2004). The TMT has an
excellent level of reliability, which ranges from 0.78 to 0.92 (Bowie & Harvey,
2006). The TMT has good concurrent validity and was correlated with the Wechsler
Adult Intelligence Scale, third version (WAIS-III), the Stroop Test, the WCST, and
cognitive tests (Sanchez-Cubillo et al., 2009).
Test of Pre-morbid Functioning (TOPF). This measure was used in
accordance with Wechsler (2011). This test is used to provide a quick estimate of a
person’s IQ and memory functioning to match the samples. The Test of Pre-morbid
Functioning (TOPF) is the revised version of the Wechsler Test of Adult Reading
(WTAR) and can be used to predict sub-scale scores on the WAIS-IV and the
Wechsler Memory Scale (WME). The TOPF has an overall high reliability, with
good internal consistency (Chronbach’s alpha = 0.95). This test was correlated with
the WAIS-IV full scale IQ score (R = .72, p < 0.001; R² = .52, p < 0.001). The
premorbid IQ score was calculated from the raw score and adjusted for years of
education and sex. This measure was used in the study to assess whether the older
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and younger groups were matched on IQ; if not, TOPF would have been included
as a covariate in the analysis.
The Hospital Anxiety and Depression Scale (HADS). This measure
was used in accordance with Zigmond and Snaith (1983). This is a self-report scale
used to screen for anxiety, depression, and general emotional distress. It consists of
14 items: 7 to assess depression and 7 to assess anxiety. The response to each
question is on a scale from 0 to 3, which means that the total score of each sub-scale
is between 0 and 21 with a clinical cutoff point of 8. The Hospital Anxiety and
Depression Scale (HADS) has a good level of internal consistency with a
Cronbach’s coefficient of 0.7 to 0.9 (Aben, Verhey, Lousberg, Lodder & Honig,
2002; Bambauer, Locke, Aupont, Mullan & McLaughlin, 2005; Bjelland, Dahl,
Haug & Neckelmann, 2002; Herrmann, 1997; Herrero et al., 2003). HADS has also
shown a good level of reliability and validity on clinically diagnosed patients and
healthy people. This test is used as a screening tool for mood as well as in the
analysis to assess whether anxiety or depression correlated with mindfulness
measures because mindfulness practice is influenced by mood. Therefore, anxiety
and depression were measured as potentially confounding variables.
Procedure
All older adult participants who contacted the researcher during the
recruitment process were screened for eligibility. Screening questions were asked
over the phone or sent via e-mail to potential participants to assess eligibility.
Similarly, all younger adults who signed up for the UCL Psychology subject pool
were screened for eligibility. Those who met the inclusion criteria were invited to
meet the researcher in a single face-to-face interview in the UCL or in their homes.
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The information sheet (see Appendix B) was e-mailed to eligible
participants and provided at the interview to ensure that the aims and the process
were coherently understood. Then, the researcher and each participant jointly
signed the consent form (see Appendix C). The demographic information was
gathered, and the measures were administered (see measure section and Appendix
D). The order of the neuropsychological measures and mindfulness measures was
counterbalanced, and within each counterbalanced block the order of the
assessments (neuropsychology or mindfulness measures) was randomised. The
research session approximately lasted for an hour and 30 minutes. The current study
was part of a wider research project (see appendix E) on the relationships among
dementia and age and the underlying abilities of cognitive behavioural therapies.
Therefore, further questionnaires related to abilities to take part in cognitive
behavioural therapy were administrated during the session in the same
counterbalanced block as the mindfulness measures. Approximately 32% of the
data were collected by a research assistant because of sample size and time
limitations.
Data Analysis
The SPSS statistical package (Version 22) was used to analyse the data.
For all continuous variables, an initial descriptive analysis was conducted to
investigate frequency and distribution and whether assumptions of normality were
met. Histogram and Q-Q plots were inspected. Skewness kurtosis values were
examined, and Kolmogorov-Smirnov tests were used to test for the significance of
any deviation from normality
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On the basis of whether parametric assumptions were met, an
independent t test or nonparametric equivalent was conducted to examine whether
the samples were matched on key variables. Where such data were nominal, a chi-
square test was performed to analyse goodness of fit. Independent t tests were used
to investigate hypotheses 1 and 2 because the assumptions of normality were met
for these variables. A number of parametric Pearson correlations were also
conducted to explore relationships between variables and eligibility for a multiple
regression, although this was not conducted in the end because of a lack of
correlations. Bonferroni correction could have been performed to adjust the P
values and reduce type I error when multiple tests were conducted. However, it was
not preformed to avoid the probability of producing type II error (Mittelhammer,
Judge & Miller, 2000).
Results
A total number of 190 people showed interest in the current study.
However, only 110 took part in the study. A number of younger adults did not meet
inclusion criteria or cancelled their appointments for no given reason. Some older
adults who showed initial interest in the study were not seen because they were
resident in areas outside London, they declined, or they did not meet inclusion
criteria. The flow through the study of younger and older participants is reported in
Figures 1 and 2 below, based on CONSORT guidance for transparent reporting of
trials (CONSORT, 2010). They state the number of participants with initial interest
for participation. Then, they show the breakdown of people who were screened,
68
excluded, withdrew and not seen because of time constrains and sample size
limitations.
Figure 1. Flow diagram for older adults (OA).
Figure 2. Flow diagram for younger adults (YA).
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The representativeness of older and younger adults who took part in relation to
those who were not included was examined using chi square. The total of included
females was (N= 74) and the total of included males was (N= 36). The total of
excluded females was (N= 49) and the total of excluded males was (N= 19) with
one missing data. The results of chi square indicated significant difference in gender
distribution between the included and excluded samples, χ2 (1) = 0.299, p = 0.58.
Participant Characteristics
The demographics of the older adults (N = 55) and younger adults (N =
55) who took part in the study are presented in Table 1.
Table 1 Participant Characteristics
Demographics OA Group (N = 55) YA Group (N = 55)
N (%) M (SD) N (%) M (SD)
Age 55 (100%) 72.5 (6.30) 55 (100%) 21.30 (2.02)
Gender
Female 34 (62%) 40 (73%)
Male 21 (38%) 15 (27%)
Ethnicity
English, Welsh,
Scottish, Northern
Irish, British
49 (89.1%) 29 (52.7%)
Irish 2 (3.6%) 0 (0%)
Gypsy or Irish
traveler
0 (0%) 1 (1.8%)
Other White 3 (5.5%) 3 (5.5%)
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Demographics OA Group (N = 55) YA Group (N = 55)
N (%) M (SD) N (%) M (SD)
White and Black
African
0 (0%) 1 (1.8%)
White and Asian 0 (0%) 1 (1.8%)
Other mixed 0 (0%) 1 (1.8%)
Indian 0 (0%) 3 (5.5% )
Chinese 0 (0%) 13 (23.6%)
Other Asian 0 (0%) 1 (1.8%)
Africa 0 (0%) 2 (3.6%)
Any other 1 (1.8%) 0 (0%)
Years of Education 55 16.7 (3.58) 55 15.36 (1.37)
TOPF 55 118.6 (9.0) 55 110.8 (7.69)
HADS
Anxiety 55 4.55 (2.88) 53 6.02 (3.4)
Depression 55 2.47 (1.8) 55 2.7 (2.44)
Note. OA = older adult; YA = younger adult.
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A chi-square test of goodness-of-fit was performed to investigate
whether ethnicity (white or nonwhite) was equally distributed in the younger and
older adult samples. The results indicated that ethnicity was not equally distributed
in the samples, χ2 (1) = 37.23, p <0.001. A chi square of goodness-of-fit was
performed also to investigate the distribution of gender in both samples. The results
suggested that gender was not equally distributed, χ2 (1) = 13.12, p <0.001. For the
exact breakdown of gender and ethnicity in both groups, refer to Table 1.
An independent t test was conducted to investigate the difference in
years of education between older and younger adults. The results revealed that there
was no statistically significant difference between older and younger adults in years
of education, t (69.6) = 1.36, p = .176, suggesting that the older and younger
samples matched in years of education. An independent t test was also used to
explore the difference between older and younger adults in TOPF and HADS. The
results suggested that TOPF scores of premorbid IQ were significantly different
between older and younger adults, t (108) = 4.91, p < 0.001. Older adults had higher
TOPF scores, potentially suggesting higher level of IQ than the younger adult
sample. The results of HADS suggested that there was a statistically significant
difference between older and younger adults with the anxiety sub-scale of HADS
being higher in the younger adult sample, t(106) = 2.422, p = .017. Conversely, the
results of the depression sub-scale of HADS suggested no significant difference
between the older and younger adult samples, t (108) = 0.75, p = 0.454.
For mindfulness measures, the MBAS histogram was slightly negatively
skewed for older adults, suggesting that older adults tended to score towards the
ceiling in cognitive control in the current study. However, the results of the
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skewness test (-1.26) and the kurtosis test (1.07) were less than 1.96, suggesting
normality of distribution. The histograms of MBAS for younger adults and both
PHLMS sub-scales (awareness and acceptance) showed normal distribution for
older and younger adults. HADS depression was positively skewed in younger
adults, suggesting that younger people scored low in depression and that they
tended to be non-depressed. The TOPF histogram for older adults was negatively
skewed, suggesting high pre-morbid IQ scores in the older adult sample.
Homogeneity of variance for all measures between older and younger groups was
investigated using Levene’s test. The results of all mindfulness measures, HADS
and TOPF were not significant, suggesting homogeneity of variance between the
older and younger groups. The results of the study allowed responses to the initial
research questions. These responses are noted below.
Research Question 1
Is there a difference in performance between an older adult group and a
younger adult group in cognitive control elements of mindfulness as measured
using the MBAS and the awareness sub-scale of the PHLMS? To examine this
hypothesis, an independent t test was performed because the data qualified the
assumptions of normal distribution and homogeneity. On the basis of the results,
the cognitive control element of mindfulness, measured using MBAS, in older
adults (M = 3.38, SE = .193) was significantly better than in younger adults (M =
2.75, SE = .188). This difference was statistically significant, t (108) = 2.36, p =
.02. The hypothesis tentatively predicted that performance on this measure would
be worse in an older adult sample than in a younger one. Therefore, the data showed
the opposite of the prediction.
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To confirm our findings, we used the awareness sub-scale of the PHLMS
to assess the cognitive control element of mindfulness. We tentatively predicted
that performance on this measure would be worse in an older adult sample than a
younger one. However, the results of independent t test suggested that the cognitive
control element of mindfulness between older (M = 35.83, SE = .70) and younger
adults (M = 36.98, SE = .67) did not significantly differ, t (108) = 1.17, p = .245.
Therefore, the data showed the opposite of the prediction.
Research Question 2
Is there a difference between an older adult group and a younger adult group
on the acceptance/non-judgment element of mindfulness assessed by the
acceptance/nonjudgmental sub-scale of the PHLMS? As with the first
hypothesis, an independent t test was conducted with our tentative prediction that
performance in this measure would be better in an older adult group than a younger
adult. The results suggested that younger adults (M = 29.82, SE = .89) were
significantly better in the acceptance/non-judgment element of mindfulness than
older adults (M = 26.52, SE = .718), t (108) = 2.86, p = 0.005. Therefore, the data
showed the opposite of the prediction.
Research Question 3
If there is an age-related difference indicated in the MBAS, is that difference
associated with changes in cognitive flexibility? We tentatively hypothesised that
if there were a difference between older and younger adults on the MBAS score, it
would be mediated by cognitive flexibility (measured by difference score on the
trail-making test). The independent t test showed significant difference between
older and younger adults, with evidence of being better in older adults, t (1) = 8.19,
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p = 0.004. Pearson’s correlation was then performed to investigate whether there
was a correlation between cognitive flexibility and MBAS. The results suggested
that there was no significant correlation between MBAS measure of cognitive
control and the TMT of cognitive flexibility, r = .098, n = 110, p = .306. Therefore,
it was not useful to do additional statistical analysis to further investigate whether
cognitive flexibility is a mediator between age and cognitive control measured by
MBAS (MacKinnon, Fairchild, & Fritz, 2007).
Table 2. Differences among the Main Variables, Comparing Older Adults and Younger
Adults
Variable OA Mean (SD) YA Mean (SD) t Test
MBAS 3.38 (1.43) 2.75 (1.39) t(108) = 2.36, p = .02
PHLMS
awareness
35.83 (5.25) 36.98 (5.01) t(108) = 1.17, p = .245
PHLMS
acceptance
26.52 (5.32) 29.82 (6.63) t(108) = 2.86, p =
0.005
TMT 41.98 (35.93) 19.85 (13.10) t(1) = 8.19, p =
0.004
Note. MBAS = Meditation Breath Attention Score; PHLMS = Philadelphia
Mindfulness Scale; TMT = Trail-Making Test.
To investigate whether any of the potential differences between the groups
were correlated with the dependent variables and thus might constitute confounds,
a series of exploratory Pearson or Spearman correlation coefficients were run to
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investigate relationships between variables and mindfulness measures. In the older
adult sample, no significant correlation existed between MBAS mindfulness
measure and any of the demographic variables, TOPF, HADS, or TMT, which
differed between the groups. A significant negative correlation existed between the
PHLMS awareness subtest and the HADS anxiety sub-scale (r = -.277, p = 0.04),
suggesting that the lower the anxiety was the higher the awareness level was. In the
younger adult sample, no significant correlation existed between MBAS
mindfulness measure and any of the variables. However, a statistically significant
negative correlation existed between PHLMS awareness subtest and HADS
depression (r = -0.34, p = 0.01).
Feasibility
During the interview, a few people complained about the length of the
25-minute MBAS task, during which participants were instructed to focus their
attention on breathing. One older and one younger adult reported dizziness after the
mindfulness task, without having any previous history of current medical condition
that might have been associated with this. A few participants had previous or
current experiences of yoga but not meditation or mindfulness. Some other
participants reported feeling distracted by some noises in the background despite
our attempt for a quiet atmosphere in the interviewing room; the noises might have
influenced their ability to focus their attention on their breathing during the
mindfulness live-experience measure.
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Discussion
Summary of Results
The aim of the current study was to investigate the effect of age on the
underlying processes of mindfulness through a comparison between older and
younger adult groups, matched in their years of education. Contrary to the first
hypothesis, the older adult group was found to perform significantly better in the
measure that tapped on the cognitive control element of mindfulness. Similarly, the
results of the second hypothesis contrasted the tentative prediction. The younger
adult group performed significantly better on the measure of acceptance/non-
judgment of mindfulness. However, the third hypothesis could not be examined
because there was no correlation between the measure of cognitive control
measured by the MBAS (Frewen et al., 2008; Frewen & Logie, 2014; Lai et al.,
2014) and the measure of cognitive flexibility suing the TMT. These findings
should be considered tentatively in light of the limitations of the current study.
Interpretation of Findings
The hypotheses of the current study were conceptualised in line with the
findings of a previous review (Prakash et al., 2014). The rationale behind predicting
that cognitive control aspects of mindfulness would be worse with age was related
to neuropsychological changes, particularly in executive functioning (Park et al.,
2002; Salthouse, 2010). On contrast, emotional regulation was suggested to
enhance or maintain with increasing age (Carstensen, Pasupathi, Mayr, &
Nesselroade, 2000; Charles, 2010; Hay & Diehl, 2011). However, the results of the
current study did not correspond with that.
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One of the interpretations of the results could be related to the
assumption that cognitive control and emotional regulation were fractionated
abilities. The results of a longitudinal study investigating the effect of age on
executive functions showed age-related decline in two particular components of
cognitive control which were task switching and response inhibition (Goh, An, &
Resnick, 2012). Similarly, emotional regulation was assumed to have various
components (Sims, Hogan, & Carstensen, 2015), and it may be that the aspects of
emotional regulation underlying acceptance did not enhance with age.
Another interpretation of the results could be related to the MBAS
(Frewen et al., 2008; Frewen & Logie, 2014; Lai et al., 2014) measure of cognitive
control being an experience sampling measure. The nature of the mindfulness task
completed by participants could have influenced the type of people who were
interested in taking part. That might have biased the data and led to over- or under-
representation of some individuals (Scollon & Kim-Prieto, 2003). During the
screening process, participants denied any previous experience of mindfulness or
meditation; therefore, the length of the breathing exercise for a naïve mindfulness
sample might not have reflected ability as much as the adjustment to a new
experience. Some participants reported feeling relaxed, which might have affected
their focus of attention, and others reported yoga experience, which might have had
a positive effect on sustaining attention. The nature of MBAS may have had an
effect on the overall performance on the measure.
It was also thought that some responses might not have reflected the measured
ability. It was clear that some participants fell asleep during the task, but they kept
raising the hand to indicate focusing their attention on their breathing. Some
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participants reported feeling relaxed after completing the task, which again raised
the question of whether they were practicing mindfulness for the first time and
whether they were controlling their attention to focus on the present moment.
Another potential methodological problem when conducting an experience
measure is the reactivity of participants to being part of a study. Reactivity means
that behaviours may change intentionally or unintentionally under examination
circumstances. Authors of a previous study suggested a strong association between
self-monitoring and sampling measures (Wheeler & Reis, 1991). This can be the
case because people may pay particular attention to their thoughts and feelings,
which may lead to changes in their behaviours.
Because of some of the strengths and weaknesses of experience measures, the
MBAS was used in addition to the awareness sub-scale of the Philadelphia
Mindfulness Measure. The reason for using a self-reported questionnaire in
addition to the experience measure was to use different assessment measures to
confirm the findings on the effect of age on cognitive control. However, the results
of second measure were not significant.
The older adult group had higher cognitive functioning than the younger adult
group. However, trail-making performance and TOPF did not correlate with
MBAS. It could have been a possible interpretation of the results that the higher
cognitive control found in the older adult group was explained by a high predicted
IQ level on TOPF measure (Wechsler, 2011).
There were significant difference between the older and younger adult
samples in their ethnicities. The results of the current study could be interpreted
considering that the ethnic and cultural background of participants influenced their
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performance on mindfulness measures. There may be an impact of cultural
differences, particularly on emotional regulation processes. Whereas Western
cultures primarily rely on active strategies to manage distress, Eastern cultures,
specifically Asian, leant towards reframing and accepting situations to deal with
difficulties (Weisz, Rothbaum, & Blackburn, 1984), perhaps leading to the finding
of higher scores on acceptance measures in the current study. A previous review
suggested that a culturally competent psychological treatment addresses the cultural
values and the concept of self and others in a therapeutic context. It suggested that
treatment disparities may be decreased with culturally responsive treatment fitting
with pre-existing coping skills (Hall, Hong, Zane, & Meyer, 2011). Perhaps the
philosophical roots of mindfulness and meditation practice might have explained
the ethnic and cultural influences on the current results.
It was also interesting that although the younger adult group was more
anxious than the older adult group, the younger adults performed better on the
acceptance measure. This finding possibly called into question the validity of the
measures of either PHLMS acceptance or HADS, and these validity issues could
also explain the findings.
Limitations
The first limitation of the current study was that the older adult sample
was recruited through contacting community centres that had access to older
people. Although researchers were contacted by interested older people from inside
and outside London, it might be that the nature of people engaged with these
organisations provided a source of sampling bias in terms of age group, gender,
ethnicity, and educational background. It seemed that the majority of our older
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sample consisted of young-old rather than old-old adults (M = 72.5, SD = 6.30).
There was also a possible influence of ethnicity as 98% of the older sample was
from a white British ethnic group.
The second limitation of the current study was that the younger adult
sample consisted mainly of UCL students and a few younger adults in the
community. The main source of recruitment was the Psychology subject pool,
which mainly targeted UCL students and staff. That might have contributed to the
wide variation in the demographics because UCL had students from various ethnic
backgrounds. The findings showed that 60% of the younger adult sample was white,
confirmed by the significant difference in ethnicity between both groups.
The third limitation was that the PHLMS measure (Cardaciotto et al.,
2008) was a self-report questionnaire completed by participants. There have been
general methodological critiques of self-report measures of mindfulness, including
exaggeration of responses, current emotional state bias, forgetting details, or social
desirability bias (Austin, Gibson, Deary, McGregor & Dent 1998).
Clinical Implications
The findings from the current study potentially indicate that cognitive
control as an underlying process of mindfulness was better in older adults than
younger adults and that the emotional control/acceptance component of
mindfulness was better in younger adults than older adults. These findings raised
the question of whether age was an influential factor to be considered when using
mindfulness clinically as an intervention. The lack of correspondence with previous
findings confirmed the importance of considering individual factors related to the
formulation rather than assuming that older or younger adults might struggle to stay
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in the present moment or take an accepting position of their emotions because of
age-related changes.
Future Research
The current study should be replicated using other mindfulness measures
that tap on cognitive control/awareness and emotional regulation/acceptance to
eliminate any possible methodological pitfalls in the measures used in the current
study. Further studies can also be conducted to assess difference between young-
old and old-old adults in the underlying processes of mindfulness practice. Another
area of future research can be the difference between people from the same age
group with and without mindfulness experience to examine the effect of
mindfulness on the underlying processes of mindfulness practice.
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Part 3: Critical Appraisal
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Introduction
This critical appraisal provides a reflection on the process of conducting
the present project. It discusses some of the challenges that arose as part of
conducting the systematic review and the empirical paper. It draws on the wider
clinical implications of older adult research. It also highlights the dilemmas
encountered at different stages of the project. It concludes with a reflection on some
of the issues in evaluating translated screening measures.
Wider Clinical Implications of Older Adult Research
Evidence suggests that clinical depression and anxiety are prevalent in
older adults (Byers, Yaffe, Covinsky, Friedman, & Bruce, 2010). This prevalence
is associated with poor quality of life, increased physical disability, and upraised
suicidal risk (Unutzer & Bruce, 2002). An increasing body of evidence is focused
on the effectiveness of psychological therapies in managing psychological distress.
As part of my clinical psychology training, it has been quite apparent how clinical
psychologists can contribute to the diagnosis and treatment of mental health issues
in older adults. Therefore, this study contributes to the development of a coherent
understanding of age-related changes that might impact psychological therapy.
The observations made during the process of this thesis suggest age-
related changes that might contribute to how people respond to mindfulness as one
of the psychological therapies with a growing body of evidence in treating anxiety
and depression. Whereas the focus of this study is the effect of age on the
underlying processes of mindfulness practice, it is important to consider individual
factors related to the conceptualised formulation rather than assuming that older or
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younger adults might struggle to stay in the present moment or to take an accepting
position of their emotions because of age-related changes.
Reflections on Recruitment, Interviews, and Engagement
This project is part of a wider ongoing research project on the underlying
abilities of cognitive behavioural therapy on a sample of people with dementia,
healthy older adults, and healthy younger adults. However, because of the required
sample size according to the power calculation and the time constraints, not all
initially interested people in London and greater London were seen in the part of
the study reported here. It is quite intriguing to reflect on the level of interest in
participation and the degree of engagement during the interviews. The leaflets were
distributed through the University of Third Age and Age UK, and they reached
areas outside London. A high volume of interested older people contacted
researchers to express their interest in taking part in the study.
During the interviewing process, I was impressed by the stories I heard from
people reflecting on their motivation for taking part in the study. Most people
reported having a partner, a sibling, or a close friend with dementia or a mental
health issue. They recognised how depression and anxiety were prevalent in older
people. Therefore, they wanted to participate as healthy individuals (used as healthy
controls) in the study to contribute to developing a better understanding of
evidence-based psychological therapies. I was also impressed by how older people
experienced taking part in a study that lasted for an average of an hour and thirty
minutes, during which they had to complete a number of tasks. People commented
on feeling productive after getting out of their homes to participate in helpful
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research. Some others commented on feeling good about taking part in a project
that might aid in tailoring psychological therapies based on people’s needs. I was
humbled by some of the appreciative comments I received from older participants.
Some of the participants felt grateful that one aim of this research project was to
contribute to providing better psychological support for older people. They were
interested to know when the results would be ready and when clinicians might have
access to the findings.
Similar to the level of engagement of the older adult sample, the level of
engagement of the younger adult sample was quite high. A few young participants
reflected on the personal meaning of participating in studies that would help in the
understanding of psychological therapies for older people. Some of them talked
about stories they experienced with older persons in their families who suffered
from dementia or psychological distress. I was impressed by how some of the young
participants connected emotionally with the process and how motivated they were
to know more about the study and its implications. There was a noticeable curiosity
about how older people from the comparison group were experiencing the
questionnaires and the mindfulness task. There was also a particular interest in how
age might have an impact on people’s cognitive and emotional functioning. I was
moved by some of the feelings and thoughts shared by the younger participants
about how much they cared about elderly people in their families. I was also
touched by feelings that came up in relation to older people in their families who
did not get the psychological support they wanted for them.
As a Trainee clinical psychologists, I have been taught to approach my
tasks from a scientific-practitioner point of view. During my interaction with
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participants, I was mindful of the aim of the meeting being a scheduled time to
collect data for research purposes. However, I was aware that the nature of our study
might bring up some different thoughts and feelings for people. While I was
working under the pressure of scheduled time-slots, I was conscious of the
importance of using my clinical skills to validate personal experiences and shared
stories within the context of research. I dedicated some time by the end of each
interview to check with participants about how they felt during the interviewing
process and if they had any further questions to ask about the nature of the study,
the questions asked, or their performance in the study.
The process of collecting data and meeting participants informed my
thinking and helped me to enhance my understanding about the various
perspectives of the study. It gave me the opportunity to learn about the potential
impact of age not only though the questionnaires and the mindfulness task, but also
through observing the pattern of answers and responses during the interview. The
design of the study was quantitate but there was a lot of information shared within
the interview that could have been of quantitative value.
Dealing with Dilemmas
In the process of conducting this research, a few dilemmas arose and were
discussed during different stages. It is through reflections on the rationale behind
our decisions that the effective directions were learnt. The dilemma provided me
with the space to think about different perspectives and encouraged me to be
mindful of the various aspects of the matter.
The first dilemma was associated with measuring the underlying abilities
of mindfulness practice. Researchers have developed numerous measures to assess
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the two main components of mindfulness: focusing attention at the present moment
and acceptance of emerging emotions. In a systematic review on the psychometric
properties of self-reported mindfulness measures, Park, Reilly-Spong, and Gross
(2013) identified approximately 10 measures of mindfulness. During the process of
identifying the appropriate measure to assess the components of mindfulness in the
current projects, we looked at how the contracts were assessed besides the validity
and reliability of the measures. We determined that it was sensible to choose a
measure that had sub-scales of awareness and acceptance and fairly excellent
psychometric properties. Therefore, we chose the Philadelphia Mindfulness
Measure (Cardaciotto, Herbert, Forman, Moitra, & Farrow, 2008). In addition, we
included the MBAS (Frewen et al., 2008; Frewen et al., 2014; Lai et al., 2015; Logie
& Frewen, 2015) as a live-experience measure of the cognitive control aspect of
awareness.
The second dilemma was related to using COSMIN (Mokkink et al., 2012) to
evaluate the quality of the translation and the cultural adaptation. The aim of the
systematic review was to review the evidence for the diagnostic accuracy of the
non-English updated versions of Addenbrooke’s Cognitive Examination (ACE)—
the ACE-Revised (ACE-R) (Mioshi et al., 2006) and the ACE-III (Hsieh et al.,
2013) —in the diagnosis of dementia. It was a natural dilemma to raise about
whether it would be beneficial to critically appraise the cross-cultural validity of
the measures using COSMIN’s appraisal tool. I was curious about the cultural
adaptation process, but I was quite surprised that most studies did not report enough
information on that matter. The conclusion of focusing on the diagnostic accuracy
aspect as the main objective of the review was the result of considering how many
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articles included detailed information on translation and cultural adaptation that
would allow a systematic appraisal. Therefore, the scope of the review was
particularly on the evidence for the diagnostic accuracy of the measures.
Issues in Evaluating Translated-Sscreening Measures
The idea of investigating the diagnostic accuracy of the translated versions of
ACE-R and ACE-III arose from acknowledging the cultural and ethnic diversity of
patients seen in clinical settings. As part of globalisation, there is an increased
awareness in the cross-cultural validity of the standardised English measures when
used with people from different cultural and ethnic backgrounds. There is also an
increased tendency to address the importance of acknowledging the influence of
cultural diversity on how patients understand the questions and if their answers
reflect their actual abilities or if their cultural knowledge may be the barrier.
The common question that clinicians ask when using psychometric measures
is about the validity of using the English screening measures with non-English
speakers, knowing that the English measures are standardised on English
populations. The question is particularly raised from the viewpoint of practicing in
a diverse city where some patients are seen with the presence of an interpreter
because of the language barrier. It is felt that as a part of maintaining good practice,
it is crucial to think about the quality of the tools we use in our assessment, which
influence our clinical decision making.
Screening measures are translated with the aim of obtaining cross-culturally
and conceptually equivalent tools in different languages (WHO, 2016). The scope
of the systematic review is on reviewing the evidence for the diagnostic accuracy
of the non-English updated versions of Addenbrooke’s Cognitive Examination
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(ACE)—the ACE-Revised (ACE-R) and the ACE-III —in the diagnosis of
dementia. ACE-R has been translated to several languages, including Brazilian,
Chinese/Mandarin, Chinese/Cantonese, French, German, Greek, Italian, Japanese,
Korean, Portuguese, Spanish, Czech, Turkish, and Spanish. Similarly, ACE-III is
translated to Spanish, Arabic, and Portuguese. However, the cultural adaptation of
the measures is not evaluated in the current literature review, which entailed
adequate reflection of the translated measure to the original version (Mokkink et
al., 2012). That is because there is a lack of detailed information on the translation
and cultural adaptation process. It is intriguing to observe a pattern of the lack of
adequate description of the translation and cultural adaptation process across the
articles included in the systematic review. Although the primary aim of the articles
is to investigate the quality of the evidence of the diagnostic accuracy of the
translated measures, it is important to report the translation and cultural adaptation
process to ensure that the tools are partially screening in the same way they are
developed for.
Reflecting on translated psychometrics tests, some clinicians suggest that
using a standardised screening tool implies that mental health issues are universal
across cultures. An oppositional viewpoint is to be skeptical about using a
standardised tool across cultures, referring to the variation in clinical presentation
in different cultures. A balanced perspective emphasises the importance of using
validated screening tools but with adaptation to the particulars of every culture,
which might involve adjusting the cutoff points (Benson & Thistlethwaite, 2009).
Arguments about the cross-cultural validity of the translated screening tools have
to be taken into consideration. However, clinicians have to be aware that the validity
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of these arguments might be compromised with dementia screening tools because
of the biological nature of the disease.
Conclusion
There is a recognised need for conducting research in the field of
psychological therapies for older people. The emotional difficulties that are
prevalent with increasing age require careful consideration of how to maintain
quality of life in the context of cognitive and emotional changes. The body of
evidence on psychological therapies for older adults is increasing. However, there
is still much that remains unknown about the interaction between the underlying
processes of psychological therapies, including mindfulness. The process of
conducting this research was quite rewarding and inspiring. Supporting research on
older adults is essential to improve their cognitive functioning and emotional well-
being. Despite the limitations of this thesis, it is a step in advancing the
understanding of the effect of age on mindfulness practice for better management
of mental health issues and enhancement of the quality of life with advanced age.
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Appendix A: Ethical Approval Letter
Ethics Approval CEHP2015531 Josh Stott
Dear Josh,
I am writing to let you know that we have approved your recent ethics
application, "CBT abilities in older people and people with dementia."
(Note to the REC - This approval does not relate to recruitment of a
dementia sample, who are to be recruited under NHS governance.)
The approval reference number is CEHP/2014/531. I have attached a copy
of your application form.
I will keep the approved forms on file, and a copy has been lodged with
the UCL Research Ethics Committee. Please notify us of any amendments,
in line with guidance on the PaLS Intranet.
Best Wishes,
John King
Chair of Ethics, CEHP
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